$ACT Company News Actavis raises guidance as earnings

New Post Public Reply Private Reply Replies (0) Message Board

Aug 5, 2014 at 10:50 AM

$ACT Company News

Actavis raises guidance as earnings top views 8:11 a.m. Today - MarketWatch.com
Nasdaq needs to turn up the volume 11:59 a.m. July 17, 2014 - The Trading Deck
Leon Cooperman talks up Citi, Thermo Fisher 11:20 a.m. July 16, 2014 - Sue Chang
Leon Cooperman likes Thermo Fisher, Citi, Actavis 11:06 a.m. July 16, 2014 - Sue Chang
10 biggest S&P 500 winners and losers for 2014 10:44 a.m. July 1, 2014 - Philip van Doorn
Affiliated Managers Group to join S&P 500 5:33 p.m. June 24, 2014 - Wallace Witkowski
10 best-performing S&P 500 stocks of 2014 2:38 p.m. June 2, 2014 - Philip van Doorn
Pfizer's plan to relocate after merger deal draws lawmakers' fire 11:30 a.m. May 9, 2014 - Russ Britt
Corner drug store may move overseas to save on taxes 6:31 a.m. April 16, 2014 - Al Lewis
Intuitive Surgical slumps; Facebook extends rally 3:41 p.m. April 9, 2014 - Sue Chang
Actavis acquires Silom Medical for $100 million 10:19 a.m. April 1, 2014 - MarketWatch.com
The 10 most overbought stocks in the S&P 500 index 12:19 p.m. March 25, 2014 - The Trading Deck
UK drug rejection, patent concerns take a bite out of Celgene shares 1:33 p.m. March 14, 2014 - Russ Britt
Mylan to start selling generic Celebrex in May 7:23 a.m. March 13, 2014 - MarketWatch.com
Pfizer loses Celebrex patent ruling; shares halted but effect muted 3:21 p.m. March 12, 2014 - Russ Britt
Staples awash in red; eBay up as Icahn posts new letter 5:09 p.m. March 6, 2014 - Sue Chang
Icahn Enterprises reports profit up 144% in 2013 11:23 a.m. March 3, 2014 - MarketWatch
Citadel hedge fund’s recent moves 12:12 p.m. Feb. 25, 2014 - Insider Monkey
Stocks rally; S&P 500 ends right below record 5:46 p.m. Feb. 24, 2014 - Victor Reklaitis
U.S. stock market is starting to ride a tech M&A wave 6:31 a.m. Feb. 24, 2014 - Wallace Witkowski

Actavis updates guidance after Q2 results 9:45 a.m. Today - Seeking Alpha
Why Akorn (AKRX) Stock Is Advancing Today 8:26 a.m. Today - TheStreet.com
UPDATE: Actavis Posts Upbeat Q2 Earnings, Raises Forecast 8:25 a.m. Today - benzinga.com
Today's Pre-Market Laggard Is Actavis (ACT) 8:25 a.m. Today - TheStreet.com
Actavis Swings to Profit 8:09 a.m. Today - The Wall Street Journal Interactive Edition
Wall Street Breakfast: AIG Settles Crisis-Era Lawsuit And Posts Profit 6:34 a.m. Today - Seeking Alpha
Jim Cramer's Top Stock Picks: ACT AMZN CAH AAPL 6:00 a.m. Today - TheStreet.com
Cramer's Mad Money - 4 Charts With Fangs (8/4/14) 5:52 a.m. Today - Seeking Alpha
Akorn receives FTC approval to acquire VersaPharm 1:53 a.m. Today - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Watch Your Back 7:59 p.m. Aug. 4, 2014 - TheStreet.com
Notable earnings before Tuesday's open 5:30 p.m. Aug. 4, 2014 - Seeking Alpha
3 Stocks Pulling The Drugs Industry Downward 1:03 p.m. Aug. 4, 2014 - TheStreet.com
Why Actavis (ACT) Might Surprise This Earnings Season - Tale of the Tape 8:36 a.m. Aug. 4, 2014 - Zacks.com
Billionaire Leon Cooperman Delivers Alpha Again 3:13 a.m. Aug. 2, 2014 - Seeking Alpha
Endo International Beats on Q2 Earnings & Sales, Guidance Up - Analyst Blog 3:36 p.m. Aug. 1, 2014 - Zacks.com
3 Eye-Catching Health Care Stocks this Earnings Season - Earnings ESP 11:44 a.m. July 31, 2014 - Zacks.com
Tax Inversion Puts These 3 Mutual Funds in Focus - Best of Funds 2:38 p.m. July 30, 2014 - Zacks.com
Undervalued Biotech Stocks Beat the Index 10:42 a.m. July 30, 2014 - Barrons.com
UPDATE: Bank Of America Reiterates On Actavis plc On Strong Strategic/Financial Position 9:54 a.m. July 29, 2014 - benzinga.com
Actavis May Give Buyers Another Chance 5:03 p.m. July 28, 2014 - Investors Business Daily

Actavis Net Revenue Increases 34% to $2.67 Billion in Second Quarter 2014; Non-GAAP EPS Increases 70% to $3.42 7:00 a.m. Today - PR Newswire - PRF
Earnings Releases, Technical Updates, FDA Acceptances, and New Products - Research Reports on Newfield Exploration, YPF, HCA, Actavis and 3M 8:50 a.m. Aug. 4, 2014 - PR Newswire - PRF
Medicines360 and Actavis Announce FDA Acceptance for Filing of NDA for Levosert™ IUD 4:30 p.m. July 21, 2014 - PR Newswire - PRF
Drug Application Submission, Merger Agreement, Launch of Newly Approved Drug, and Acquisition - Analyst Notes on Actavis, Salix, Mylan, Zoetis and Hospira 5:10 a.m. July 14, 2014 - PR Newswire - PRF
Actavis Confirms Generic Diclegis® Patent Challenge 4:25 p.m. July 11, 2014 - PR Newswire - PRF
Actavis Confirms Generic Ampyra® Patent Challenge 4:05 p.m. July 8, 2014 - PR Newswire - PRF
Board Changes, Patents, Recognitions, and Technical Updates - Analyst Notes on Actavis, Celldex Therapeutics, Galena Biopharma, PTC Therapeutics and Theravance Biopharma 5:30 a.m. July 4, 2014 - PR Newswire - PRF
Impax Acquires Two Products from Actavis 4:05 p.m. July 2, 2014 - PR Newswire - PRF
Actavis Completes Acquisition of Furiex Pharmaceuticals 8:46 a.m. July 2, 2014 - PR Newswire - PRF
Actavis Announces Final Stockholder Merger Consideration Election Results in Connection with Forest Laboratories Acquisition 8:00 a.m. July 2, 2014 - PR Newswire - PRF
Furiex Stockholders Approve Acquisition by Actavis; Ukrainian Antimonopoly Committee Clears Proposed Merger 3:15 p.m. July 1, 2014 - BusinessWire - BZX
Fitch Rates Forest Labs Bonds 'BBB-', Affirms Actavis at 'BBB-'; Outlook Stable 10:08 a.m. July 1, 2014 - BusinessWire - BZX
Actavis plc Appoints New Members and Announces Changes to Board of Directors Following Close of Forest Laboratories, Inc. Acquisition 9:00 a.m. July 1, 2014 - PR Newswire - PRF
Actavis Completes Forest Laboratories Acquisition 8:20 a.m. July 1, 2014 - PR Newswire - PRF
Stocks Coverage on the Pharma Industry -- Research on Zoetis, Mylan, AVANIR Pharma, and Actavis 6:50 a.m. July 1, 2014 - PR Newswire - PRF
Actavis and Forest Receive U.S. FTC Clearance for Actavis’ Proposed Acquisition of Forest 5:15 p.m. June 30, 2014 - BusinessWire - BZX
Actavis and Forest Receive U.S. FTC Clearance for Actavis' Proposed Acquisition of Forest 5:15 p.m. June 30, 2014 - PR Newswire - PRF
Actavis and Forest Announce Preliminary Stockholder Merger Consideration Election Results 8:30 a.m. June 30, 2014 - BusinessWire - BZX
Actavis and Forest Announce Preliminary Stockholder Merger Consideration Election Results 8:30 a.m. June 30, 2014 - PR Newswire - PRF
Actavis to Host Second Quarter 2014 Earnings Conference Call and Webcast 8:00 a.m. June 30, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Unicycive Faces Legal Heat Amid Stock Tumble

Unicycive Therapeutics' Rough Ride In this wild market, sometimes even the most seasoned investors get blindsided. Unicycive Therapeutics (NASDAQ: UNC) shareholders are currently caught in a storm with their stock nose-diving by 39.1% on June 30, 2026. It's like being taken to the cleaners without the decency of a warning. Failed Expectations & FDA Blues Here's the...

Horowitz's $150M Boost for Nevada's First Children's Hospital

Big Bucks and Bigger Hearts Boost Pediatric Care in Nevada The world isn't exactly short on folks looking to make a buck, but every so often, someone comes along and wants to make a difference instead. Enter Felicia and Ben Horowitz, handing over a staggering $150 million to Intermountain Health. This isn’t your garden-variety gift—it’s aimed at getting Nevada on...

Lassa's Wintus 3: Boosting Winter Tyre Game for 2026

Rolling Through Winter: Lassa's Next Step Ever felt like you were skating on thin ice with your vehicle in winter? That's why Lassa has cranked out the Wintus 3—a tyre making waves in the chilly game. Now, we're not talking about your run-of-the-mill rubber. This is a strategic play by a Turkish powerhouse, Brisa, aimed squarely at those who rely on light commercial...

York Space Systems Class Action: Deadline Approaches

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

FDA Nod for Subcutaneous SKYRIZI in Crohn's Disease

AbbVie's Injection Makes Waves in Crohn's Treatment Here's a bit of medicine shake-up for you. AbbVie just snagged FDA approval for its subcutaneous SKYRIZI—specifically designed for adults battling moderately to severely active Crohn's disease. This news isn't just a blip on the radar; it's significant for patients and the healthcare landscape. We're talking about new...

HSG's Laser Tech Dazzles at FABTECH 2026

Laser Innovations on Display at FABTECH 2026 Listen up, folks—FABTECH 2026 in Vegas is where HSG Laser decided to flaunt their new toys, codenamed TS2 PRO and the mystical AI CutPilot. Now, unless you've been living under a rock, you'll know HSG is all about shaking up the laser cutting scene. They've done it for two decades, and now they're pushing the envelope with...

Hidden Assets Guide: Essential Tool for Attorneys

Asset Searches: Why They Matter to Lawyers Some days you just have to get into the nitty-gritty of legal legwork, and today feels like one of those days. Asset Search USA has come out swinging with a practical guide that no attorney should ignore, especially if they're dealing with the shadowy world of hidden assets. What are we talking about here? We're talking about...

Egan-Jones CLO Metrics Strong Amid Rate Hikes

Interest Rates Climb, CLO Metrics Hold Firm Buckle up, folks. As interest rates drift higher like a stubborn balloon, investors are scouring the landscape for any sign of a shaky foundation. Well, here's a bit of solace in the storm: Egan-Jones, the credit rating powerhouse, has released their latest musings on the collateralized loan obligation (CLO) market...

SAFE Structure Designs Backs Prosthetic Nonprofit 50 Legs

A Partnership Rooted in Service and Faith Let's face it, support from major companies for nonprofits isn't exactly commonplace. But every so often, you run into a partnership that catches your eye, and this one's got a little extra heart. SAFE Structure Designs, known for its defense engineering prowess in Las Vegas, is throwing its weight behind Clearwater's 50 Legs....

Concrete Admixtures Market: A Billion-Dollar Boom

A Look Under the Hood of Concrete Admixtures It's a concrete jungle out there, folks—literally. The once overlooked market of concrete admixtures is gearing up for quite the makeover, projected to hit USD 35.87 billion by 2035. For those of you tuning in, we're talking about chemicals that mix into your average concrete to change its properties. And, believe it or not,...